Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Statistical considerations for assessing cognition and neuropathology associations in preclinical Alzheimer's disease

Statistical considerations for assessing cognition and neuropathology associations in preclinical... Analysis of the associations between the neuropathology of Alzheimer's disease (AD) and cognition has become a major area of investigation as both basic and clinical researchers have turned their attention toward identifying the factors underlying the onset of preclinical AD. Here we provide a conceptual overview of statistical approaches for analyzing associations between cognition and AD neuropathology in the context of the prodromal AD. The review will discuss a variety of statistical approaches, their application to various clinical pathological variables, and research questions, as well as the importance of accounting for and including interaction terms in statistical models. The overview presented here will introduce data analysts and statisticians to the nomenclature of AD neuropathology and provide relevant background information regarding the nature of cognitive and neuropathological data generated in the investigation of preclinical AD. In addition, we will introduce a number of statistical approaches that researchers who specialize in AD neuropathology may utilize in their studies. For both audiences, this review will provide an applied statistical framework to draw from for future research. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Biostatistics & Epidemiology Taylor & Francis

Statistical considerations for assessing cognition and neuropathology associations in preclinical Alzheimer's disease

Download PDF

Statistical considerations for assessing cognition and neuropathology associations in preclinical Alzheimer's disease

Abstract

Analysis of the associations between the neuropathology of Alzheimer's disease (AD) and cognition has become a major area of investigation as both basic and clinical researchers have turned their attention toward identifying the factors underlying the onset of preclinical AD. Here we provide a conceptual overview of statistical approaches for analyzing associations between cognition and AD neuropathology in the context of the prodromal AD. The review will discuss a variety of statistical...
Loading next page...
 
/lp/taylor-francis/statistical-considerations-for-assessing-cognition-and-neuropathology-Z3l440THkK
Publisher
Taylor & Francis
Copyright
© 2017 International Biometric Society – Chinese Region
ISSN
2470-9379
eISSN
2470-9360
DOI
10.1080/24709360.2017.1342186
Publisher site
See Article on Publisher Site

Abstract

Analysis of the associations between the neuropathology of Alzheimer's disease (AD) and cognition has become a major area of investigation as both basic and clinical researchers have turned their attention toward identifying the factors underlying the onset of preclinical AD. Here we provide a conceptual overview of statistical approaches for analyzing associations between cognition and AD neuropathology in the context of the prodromal AD. The review will discuss a variety of statistical approaches, their application to various clinical pathological variables, and research questions, as well as the importance of accounting for and including interaction terms in statistical models. The overview presented here will introduce data analysts and statisticians to the nomenclature of AD neuropathology and provide relevant background information regarding the nature of cognitive and neuropathological data generated in the investigation of preclinical AD. In addition, we will introduce a number of statistical approaches that researchers who specialize in AD neuropathology may utilize in their studies. For both audiences, this review will provide an applied statistical framework to draw from for future research.

Journal

Biostatistics & Epidemiology – Taylor & Francis

Published: Jan 1, 2017

Keywords: Non-parametric; statistical analysis; mild cognitive impairment; amyloid plaque; neurofibrillary tangle; dementia

References

  • Molecular and cellular pathophysiology of preclinical Alzheimer's disease
  • Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
  • Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers
  • Neuropathology of non-Alzheimer degenerative disorders
  • Neuritic and diffuse plaque associations with memory in non-cognitively impaired elderly
  • Interaction of neuritic plaques and education predicts dementia
  • Neuropathological alterations in Alzheimer disease
  • Alzheimer's disease and the amyloid cascade hypothesis: a critical review
  • Theoretical impact of Florbetapir (18F) amyloid imaging on the diagnosis of Alzheimer's dementia and the detection of preclinical cortical amyloid
  • PET imaging of tau pathology in Alzheimer's disease and tauopathies
  • Classification and epidemiology of MCI
  • Alzheimer's Prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible
  • The A4 study: stopping AD before symptoms begin?
  • The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  • Neuropathological stageing of Alzheimer-related changes
  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
  • The National Institute on Aging, and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease: consensus recommendations for the postmortem diagnosis of Alzheimer's disease
  • National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
  • Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
  • The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
  • Should we always choose a nonparametric test when comparing two apparently nonnormal distributions?
  • Performance of five two-sample location tests for skewed distributions with unequal variances
  • T-tests, non-parametric tests, and large studies - a paradox of statistical practice
  • Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment
  • Cognitive performance on the Mini-Mental State Examination and the Montreal Cognitive Assessment across the healthy adult lifespan
  • Log transformation: application and interpretation in biomedical research
  • KIF6 719Arg carrier status association with homocysteine and c-reactive protein in amnestic mild cognitive impairment and Alzheimer's disease patients
  • Overdispersion and Poisson regression
  • Zero inflated Poisson and negative binomial regression models: application in education
  • The negative binomial distribution
  • Fixed effects negative binomial regression models
  • Robust mediation analysis based on median regression
  • Using AIC in multiple linear regression framework with multiply imputed data
  • Epidemiological pathology of tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study
  • Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint
  • A conceptual and empirical examination of justifications for dichotomization
  • Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology
  • Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition
  • Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
  • Cognitive measures predict pathologic Alzheimer disease
  • Braak stage and trajectory of cognitive decline in non-cognitively impaired elders
  • Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
  • Preclinical AD Workgroup staging: pathological correlates and potential challenges
  • The evolution of preclinical Alzheimer's disease: implications for prevention trials
  • Ushering in the study and treatment of preclinical Alzheimer disease
  • Real longitudinal data analysis for real people: building a good enough mixed model
  • Modelling covariance structure in the analysis of repeated measures data
  • Statistical analysis of longitudinal neuroimage data with linear mixed effects models
  • Evaluation of overall treatment effect in MMRM
  • The preclinical Alzheimer cognitive composite: measuring amyloid-related decline
  • Mediators and moderators in early intervention research
  • APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls
  • Interaction of neuritic plaques and education predicts dementia
  • The relationship between complement factor C3, APOE ϵ4, amyloid and tau in Alzheimer's disease
  • APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
  • Synergistic interactions between Aβ, tau, and α-synuclein: acceleration of neuropathology and cognitive decline
  • A two-process model for neuropathology of Alzheimer's disease
  • The effect of ignoring statistical interactions in regression analyses conducted in epidemiologic studies: an example with survival analysis using Cox proportional hazards regression model
  • Berkson's bias, selection bias, and missing data
  • Does the source of subjects matter? Absolutely!
  • Selection bias due to loss to follow up in cohort studies
  • Frequent cognitive assessments may obscure cognitive decline
  • An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
  • Methodological challenges in causal research on racial and ethnic patterns of cognitive trajectories: measurement, selection, and bias
  • Overadjustment bias and unnecessary adjustment in epidemiologic studies